Celmatix
Robert O'Connell has over 25 years of experience managing financial operations. Prior to joining Celmatix, he was the Financial Controller at eFront Financial Solutions overseeing multiple North American entities. He also held similar roles at Cantor Fitzgerald and Thomson Financial. Robert received his MBA from Pace University and his Bachelor of Arts in Accounting from William Paterson University.
This person is not in any teams
This person is not in any offices
Celmatix
Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health.